Craft
  • Home
  •  / APEIRON Biologics
APEIRON Biologics

APEIRON Biologics

APEIRON Biologics Summary

Company summary

Overview
APEIRON Biologics is a biotech company focused on the discovery and development of cancer immunotherapies. Its product APN311 is an autologous cellular therapy to enhance immune reactivity via an intracellular immune master checkpoint. APEIRON's solution is developed for the treatment of pediatric neuroblastoma patients.
Type
Private
Founded
2005
HQ
Wien, AT | view all locations
Website
https://www.apeiron-biologics.com/
Cybersecurity rating
Sectors

Key people

  • Peter Llewellyn-Davies

    Peter Llewellyn-Davies, Chief Executive Officer, Chief Financial Officer

    • Andreas Stadler

      Andreas Stadler, Director Finance

    • Romana Gugenberger

      Romana Gugenberger, Chief Medical & Scientific Officer (CMSO)

      • Andreas Gerber

        Andreas Gerber, Chief Operating Officer (COO)

        LocationsView all

        1 location detected

        • Wien, Wien HQ

          Austria

          Campus-Vienna-Biocenter 5

        Footer menu